Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.

Eli Lilly announced plans to construct a $6 billion pharmaceutical manufacturing facility in Huntsville, aiming to enhance ...

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

Just after market close on Monday, Dyne announced that it has launched an underwritten public offering of $300 million worth of its common stock. The underwriters of the issue, which include Morgan ...

Work culture and overall compensation remain important career components for medical marketers, even as average salaries ...

Abivax is preparing a regulatory submission in the U.S. in the second half of 2026, provided an ongoing maintenance trial ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Today we discuss why comparing U.S. vaccine policy to Europe’s is a red herring, why the revolving door at the FDA between ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

What China is accomplishing in R&D “has implications for everyone playing in the R&D or innovation world,” McKinsey’s ...